U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis



Details

  • Personal Author:
  • Description:
    Purpose: The mouse double minute 2 homologue (MDM2) -309T/G promoter polymorphism has been associated recently with the development and prognosis of a variety of tumors. The G allele is associated with increased affinity for Sp1 binding and higher MDM2 mRNA and protein levels, leading to diminished tumor suppressor activity of the p53 pathway. We hypothesized that the G allele is also associated with increased risk and worse outcome in pancreatic cancer. Experimental design: We evaluated the association between MDM2 309T/G and the risk of histologically confirmed pancreatic adenocarcinoma at Massachusetts General Hospital using unconditional logistic regression (123 cases and 372 controls). Complete overall survival and progression-free survival data were also available for 109 newly diagnosed patients. Results: The adjusted odds ratios (95% confidence intervals) of pancreatic cancer associated with the MDM2 T/G and G/G genotypes compared with TT were 1.89 (1.20-2.99) and 2.07 (1.03-4.16), respectively (adjusting for age, gender, smoking status, and pack-years of smoking). In Cox proportional hazards model with the wild-type T/T genotype as the reference category and adjusting for stage, treatment, and performance status, both the heterozygous T/G and the homozygous G/G genotypes were associated with decreased progression-free survival [adjusted hazard ratio (95% confidence interval), 1.67 (0.98-2.84) for T/G and 2.28 (1.11-4.71) for G/G] and overall survival [2.64 (1.23-5.67) for T/G and 3.12 (1.22-7.91) for G/G]. Conclusions: The G allele of the MDM2 -309T/G polymorphism is associated with 2- to 3-fold increase risk and progression of pancreatic adenocarcinoma and a corresponding decrease in survival. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    1078-0432
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    14
  • Issue:
    12
  • NIOSHTIC Number:
    nn:20060033
  • Citation:
    Clin Cancer Res 2008 Jun; 14(12):4010-4015
  • Contact Point Address:
    Geoffrey Liu, 610 UniversityAvenue, Room 7-124,Toronto, Ontario, Canada M5G-2M9
  • Email:
    Geoffrey.Liu@uhn.on.ca
  • Federal Fiscal Year:
    2008
  • Performing Organization:
    Harvard School of Public Health
  • Peer Reviewed:
    True
  • Start Date:
    20050701
  • Source Full Name:
    Clinical Cancer Research
  • End Date:
    20280630
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:e00b6a28fef9f5e2f0f58d5a37fcc03311776ed5a8b307e92f0beae105a1f6a426399c0f1f72f19bb15990866a1a9e3b45a01c5429dc54fb9b8356a97bf63dc7
  • Download URL:
  • File Type:
    Filetype[PDF - 201.63 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.